Research and experimental development on natural sciences and engineering
NYKODE THERAPEUTICS ASA
Revenue 2024
NOK 9.2m
Operating profit
NOK −45.7m
Equity
NOK 140.1m
Incorporated
2006
Employees
46
Share capital
NOK 3.3m
Key figures · 2024
Current ratio
14.30
Equity ratio
89.8%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -499.5% | |
| Net margin (%%) | -420.2% | |
| Return on assets (%%) | -29.3% | |
| Likviditet | ||
| Current ratio | 14.30 | |
| Working capital | 107.5m | |
| Soliditet | ||
| Equity ratio (%%) | 89.8% | |
| Debt-to-equity ratio | 0.11 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.